Antiviral Drugs Have No Effect on Mortality in COVID-19
Remdesivir, hydroxychloroquine, lopinavir, interferon regimens have little to no effect on in-hospital mortality
remdesivir
U.S. Supply of COVID-19 Therapeutics Seems Stable, for Now
In September, as doctors prepared for a fall and winter COVID-19 surge across the U.S., they sounded alarms about inadequate supplies of the antiviral medication remdesivir to treat their patients. But that supply concern seems to have been addressed: Gilead, remdesivir’s U.S. manufacturer, confirmed that they are “meeting real-time, global demand” in an email to…
FDA Issues EUA to Baricitinib Plus Remdesivir for COVID-19
Emergency use authorization applies to hospitalized patients requiring supplemental oxygen, mechanical ventilation, ECMO
COVID-19 Antibody Treatment Study Paused
ACTIV-3 study, testing use of an antibody therapy with remdesivir, paused ‘out of an abundance of caution’
-
Loading...
-
Loading...
Next post in News
